Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling

Abstract

A major challenge in neuroscience is to determine the nanoscale position and quantity of signaling molecules in a cell type– and subcellular compartment–specific manner. We developed a new approach to this problem by combining cell-specific physiological and anatomical characterization with super-resolution imaging and studied the molecular and structural parameters shaping the physiological properties of synaptic endocannabinoid signaling in the mouse hippocampus. We found that axon terminals of perisomatically projecting GABAergic interneurons possessed increased CB1 receptor number, active-zone complexity and receptor/effector ratio compared with dendritically projecting interneurons, consistent with higher efficiency of cannabinoid signaling at somatic versus dendritic synapses. Furthermore, chronic Δ9-tetrahydrocannabinol administration, which reduces cannabinoid efficacy on GABA release, evoked marked CB1 downregulation in a dose-dependent manner. Full receptor recovery required several weeks after the cessation of Δ9-tetrahydrocannabinol treatment. These findings indicate that cell type–specific nanoscale analysis of endogenous protein distribution is possible in brain circuits and identify previously unknown molecular properties controlling endocannabinoid signaling and cannabis-induced cognitive dysfunction.

This is a preview of subscription content

Access options

Buy article

Get time limited or full article access on ReadCube.

$32.00

All prices are NET prices.

Figure 1: 3D-STORM imaging of CB1 receptors on hippocampal GABAergic axon terminals.
Figure 2: Cell type–specific integrated analysis of physiological properties, anatomical parameters and nanoscale molecular imaging.
Figure 3: Perisomatic boutons are larger and contain proportionally more CB1 receptors compared with dendritic boutons.
Figure 4: Cell type–specific multicolor STORM imaging illuminates homogeneous nanoscale distribution of CB1 receptors on GABAergic axon terminals.
Figure 5: Cell type–specific and size-independent active zone architecture of GABAergic interneurons.
Figure 6: Chronic THC treatment induces long-lasting loss of CB1 from the plasma membrane of GABAergic axon terminals in a dose-dependent manner.

References

  1. Klausberger, T. & Somogyi, P. Neuronal diversity and temporal dynamics: the unity of hippocampal circuit operations. Science 321, 53–57 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Lichtman, J.W. & Denk, W. The big and the small: challenges of imaging the brain's circuits. Science 334, 618–623 (2011).

    CAS  Article  PubMed  Google Scholar 

  3. O'Rourke, N.A., Weiler, N.C., Micheva, K.D. & Smith, S.J. Deep molecular diversity of mammalian synapses: why it matters and how to measure it. Nat. Rev. Neurosci. 13, 365–379 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  4. Hangya, B., Pi, H.J., Kvitsiani, D., Ranade, S.P. & Kepecs, A. From circuit motifs to computations: mapping the behavioral repertoire of cortical interneurons. Curr. Opin. Neurobiol. 26, 117–124 (2014).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  5. Choquet, D. & Triller, A. The dynamic synapse. Neuron 80, 691–703 (2013).

    CAS  Article  PubMed  Google Scholar 

  6. Kano, M., Ohno-Shosaku, T., Hashimotodani, Y., Uchigashima, M. & Watanabe, M. Endocannabinoid-mediated control of synaptic transmission. Physiol. Rev. 89, 309–380 (2009).

    CAS  Article  PubMed  Google Scholar 

  7. Katona, I. & Freund, T.F. Multiple functions of endocannabinoid signaling in the brain. Annu. Rev. Neurosci. 35, 529–558 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  8. Lovinger, D.M. Presynaptic modulation by endocannabinoids. Handb. Exp. Pharmacol. 184, 435–477 (2008).

    CAS  Article  Google Scholar 

  9. Katona, I. et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J. Neurosci. 19, 4544–4558 (1999).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  10. Wilson, R.I. & Nicoll, R.A. Endogenous cannabinoids mediate retrograde signaling at hippocampal synapses. Nature 410, 588–592 (2001).

    CAS  Article  PubMed  Google Scholar 

  11. Ohno-Shosaku, T., Maejima, T. & Kano, M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29, 729–738 (2001).

    CAS  Article  PubMed  Google Scholar 

  12. Klausberger, T. et al. Complementary roles of cholecystokinin- and parvalbumin-expressing GABAergic neurons in hippocampal network oscillations. J. Neurosci. 25, 9782–9793 (2005).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  13. Tricoire, L. et al. A blueprint for the spatiotemporal origins of mouse hippocampal interneuron diversity. J. Neurosci. 31, 10948–10970 (2011).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  14. Miles, R., Toth, K., Gulyas, A.I., Hajos, N. & Freund, T.F. Differences between somatic and dendritic inhibition in the hippocampus. Neuron 16, 815–823 (1996).

    CAS  PubMed  Article  Google Scholar 

  15. Lee, S.H., Földy, C. & Soltesz, I. Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus. J. Neurosci. 30, 7993–8000 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  16. Hoffman, A.F., Oz, M., Yang, R., Lichtman, A.H. & Lupica, C.R. Opposing actions of chronic Δ9-tetrahydrocannabinol and cannabinoid antagonists on hippocampal long-term potentiation. Learn. Mem. 14, 63–74 (2007).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  17. Puighermanal, E. et al. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat. Neurosci. 12, 1152–1158 (2009).

    CAS  Article  PubMed  Google Scholar 

  18. Puighermanal, E. et al. Dissociation of the pharmacological effects of THC by mTOR blockade. Neuropsychopharmacology 38, 1334–1343 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  19. Maglione, M. & Sigrist, S.J. Seeing the forest tree by tree: super-resolution light microscopy meets the neurosciences. Nat. Neurosci. 16, 790–797 (2013).

    CAS  Article  PubMed  Google Scholar 

  20. Rust, M.J., Bates, M. & Zhuang, X. Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM). Nat. Methods 3, 793–795 (2006).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  21. Vida, I., Halasy, K., Szinyei, C., Somogyi, P. & Buhl, E.H. Unitary IPSPs evoked by interneurons at the stratum radiatum-stratum lacunosum-moleculare border in the CA1 area of the rat hippocampus in vitro. J. Physiol. (Lond.) 506, 755–773 (1998).

    CAS  Article  Google Scholar 

  22. MacGillavry, H.D., Song, Y., Raghavachari, S. & Blanpied, T.A. Nanoscale scaffolding domains within the postsynaptic density concentrate synaptic AMPA receptors. Neuron 78, 615–622 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  23. Nair, D. et al. Super-resolution imaging reveals that AMPA receptors inside synapses are dynamically organized in nanodomains regulated by PSD95. J. Neurosci. 33, 13204–13224 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  24. Specht, C.G. et al. Quantitative nanoscopy of inhibitory synapses: counting gephyrin molecules and receptor binding sites. Neuron 79, 308–321 (2013).

    CAS  PubMed  Article  Google Scholar 

  25. Hefft, S. & Jonas, P. Asynchronous GABA release generates long-lasting inhibition at a hippocampal interneuron-principal neuron synapse. Nat. Neurosci. 8, 1319–1328 (2005).

    CAS  PubMed  Article  Google Scholar 

  26. Wilson, R.I., Kunos, G. & Nicoll, R.A. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31, 453–462 (2001).

    CAS  Article  PubMed  Google Scholar 

  27. Dani, A., Huang, B., Bergan, J., Dulac, C. & Zhuang, X. Superresolution imaging of chemical synapses in the brain. Neuron 68, 843–856 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  28. Frank, T. et al. Bassoon and the synaptic ribbon organize Ca2+ channels and vesicles to add release sites and promote refilling. Neuron 68, 724–738 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  29. Herlitze, S. et al. Modulation of Ca2+ channels by G-protein beta gamma subunits. Nature 380, 258–262 (1996).

    CAS  PubMed  Article  Google Scholar 

  30. Holderith, N. et al. Release probability of hippocampal glutamatergic terminals scales with the size of the active zone. Nat. Neurosci. 15, 988–997 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  31. Wilhelm, B.G. et al. Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins. Science 344, 1023–1028 (2014).

    CAS  Article  PubMed  Google Scholar 

  32. Bass, C.E. & Martin, B.R. Time course for the induction and maintenance of tolerance to Δ(9)-tetrahydrocannabinol in mice. Drug Alcohol Depend. 60, 113–119 (2000).

    CAS  PubMed  Article  Google Scholar 

  33. Heishman, S.J., Huestis, M.A., Henningfield, J.E. & Cone, E.J. Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacol. Biochem. Behav. 37, 561–565 (1990).

    CAS  PubMed  Article  Google Scholar 

  34. Varvel, S.A. et al. Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic and cataleptic effects of marijuana in mice. J. Pharmacol. Exp. Ther. 314, 329–337 (2005).

    CAS  PubMed  Article  Google Scholar 

  35. Carlson, G., Wang, Y. & Alger, B.E. Endocannabinoids facilitate the induction of LTP in the hippocampus. Nat. Neurosci. 5, 723–724 (2002).

    CAS  PubMed  Article  Google Scholar 

  36. Chevaleyre, V. & Castillo, P.E. Endocannabinoid-mediated metaplasticity in the hippocampus. Neuron 43, 871–881 (2004).

    CAS  PubMed  Article  Google Scholar 

  37. Bolla, K.I., Brown, K., Eldreth, D., Tate, K. & Cadet, J.L. Dose-related neurocognitive effects of marijuana use. Neurology 59, 1337–1343 (2002).

    CAS  PubMed  Article  Google Scholar 

  38. Hirvonen, J. et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol. Psychiatry 17, 642–649 (2012).

    CAS  PubMed  Article  Google Scholar 

  39. Stott, C.G., White, L., Wright, S., Wilbraham, D. & Guy, G.W. A phase I study to assess the single and multiple dose pharmacokinetics of THC/CBD oromucosal spray. Eur. J. Clin. Pharmacol. 69, 1135–1147 (2013).

    CAS  PubMed  Article  Google Scholar 

  40. DeLong, G.T., Wolf, C.E., Poklis, A. & Lichtman, A.H. Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol. Drug Alcohol Depend. 112, 126–133 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  41. Chen, K. et al. Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 39, 599–611 (2003).

    CAS  PubMed  Article  Google Scholar 

  42. Ludányi, A. et al. Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J. Neurosci. 28, 2976–2990 (2008).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  43. Maccarrone, M. et al. Abnormal mGlu 5 receptor/endocannabinoid coupling in mice lacking FMRP and BC1 RNA. Neuropsychopharmacology 35, 1500–1509 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  44. Zhang, L. & Alger, B.E. Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome. J. Neurosci. 30, 5724–5729 (2010).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  45. Jung, K.M. et al. Uncoupling of the endocannabinoid signalling complex in a mouse model of fragile X syndrome. Nat. Commun. 3, 1080 (2012).

    PubMed  Article  CAS  Google Scholar 

  46. Shigemoto, R. et al. Target cell–specific concentration of a metabotropic glutamate receptor in the presynaptic active zone. Nature 381, 523–525 (1996).

    CAS  PubMed  Article  Google Scholar 

  47. Mikasova, L., Groc, L., Choquet, D. & Manzoni, O.J. Altered surface trafficking of presynaptic cannabinoid type 1 receptor in and out synaptic terminals parallels receptor desensitization. Proc. Natl. Acad. Sci. USA 105, 18596–18601 (2008).

    CAS  PubMed  Article  PubMed Central  Google Scholar 

  48. Huestis, M.A. et al. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Arch. Gen. Psychiatry 58, 322–328 (2001).

    CAS  PubMed  Article  Google Scholar 

  49. Volkow, N.D., Baler, R.D., Compton, W.M. & Weiss, S.R. Adverse health effects of marijuana use. N. Engl. J. Med. 370, 2219–2227 (2014).

    PubMed  PubMed Central  Article  CAS  Google Scholar 

  50. Pertwee, R.G. Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities. Phil. Trans. R. Soc. Lond. B 367, 3353–3363 (2012).

    CAS  Article  Google Scholar 

  51. Tappe-Theodor, A. et al. A molecular basis of analgesic tolerance to cannabinoids. J. Neurosci. 27, 4165–4177 (2007).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  52. Fukudome, Y. et al. Two distinct classes of muscarinic action on hippocampal inhibitory synapses: M2-mediated direct suppression and M1/M3-mediated indirect suppression through endocannabinoid signalling. Eur. J. Neurosci. 19, 2682–2692 (2004).

    PubMed  Article  Google Scholar 

  53. Zimmer, A., Zimmer, A.M., Hohmann, A.G., Herkenham, M. & Bonner, T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA 96, 5780–5785 (1999).

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  54. Nyilas, R. et al. Enzymatic machinery for endocannabinoid biosynthesis associated with calcium stores in glutamatergic axon terminals. J. Neurosci. 28, 1058–1063 (2008).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  55. Varga, C., Golshani, P. & Soltesz, I. Frequency-invariant temporal ordering of interneuronal discharges during hippocampal oscillations in awake mice. Proc. Natl. Acad. Sci. USA 109, E2726–E2734 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  56. Dick, O. et al. The presynaptic active zone protein bassoon is essential for photoreceptor ribbon synapse formation in the retina. Neuron 37, 775–786 (2003).

    CAS  PubMed  Article  Google Scholar 

  57. Bates, M., Huang, B., Dempsey, G.T. & Zhuang, X. Multicolor super-resolution imaging with photo-switchable fluorescent probes. Science 317, 1749–1753 (2007).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  58. Baranyi, M., Cervenak, J., Bender, B. & Kacskovics, I. Transgenic rabbits that overexpress the neonatal Fc receptor (FcRn) generate higher quantities and improved qualities of anti-thymocyte globulin (ATG). PLoS ONE 8, e76839 (2013).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  59. Huang, B., Wang, W., Bates, M. & Zhuang, X. Three-dimensional super-resolution imaging by stochastic optical reconstruction microscopy. Science 319, 810–813 (2008).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  60. Deschout, H. et al. Precisely and accurately localizing single emitters in fluorescence microscopy. Nat. Methods 11, 253–266 (2014).

    CAS  Article  PubMed  Google Scholar 

  61. Thévenaz, P., Ruttimann, U.E. & Unser, M. A pyramid approach to subpixel registration based on intensity. IEEE Trans. Image Process. 7, 27–41 (1998).

    Article  PubMed  Google Scholar 

  62. Ester, M., Kriegel, H.-P., Sander, J. & Xu, X. A density-based algorithm for discovering clusters in large spatial databases with noise. in Proc. 2nd Int. Conf. Knowl. Discov. Data Min. (eds. Simoudis, E., Han, J. & Fayyad, U.) 226–231 (1996).

  63. Veatch, S.L. et al. Correlation functions quantify super-resolution images and estimate apparent clustering due to over-counting. PLoS ONE 7, e31457 (2012).

    CAS  PubMed  PubMed Central  Article  Google Scholar 

  64. McKinney, D.L. et al. Dose-related differences in the regional pattern of cannabinoid receptor adaptation and in vivo tolerance development to delta9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 324, 664–673 (2008).

    CAS  PubMed  Article  Google Scholar 

Download references

Acknowledgements

We are grateful to E. Tischler and G. Goda for their excellent technical assistance, I. Mihály for bouton distribution analysis, and C. Cserép and C. Fekete for their help with immunostaining and antibody labeling protocols. The authors are indebted to A. Zimmer (University of Bonn) for providing the CB1 knockout mouse line and to A. Tímár for his help with software analysis. We also thank N. Hájos, N. Holderith, N. Lenkey and Z. Nusser for their comments on the manuscript. The help of the Nikon Microscopy Center at the Institute of Experimental Medicine, Nikon Europe B.V., Nikon Austria GmbH and Auro-Science Consulting is greatly acknowledged for kindly providing microscopy support. This study was primarily supported by the European Research Council Grant 243153 and by the Momentum Program (LP2013-54/2013) of the Hungarian Academy of Sciences to I. Katona. The project was also funded by the Hungarian Academy of Sciences Equipment Grant (IF-22/2012) for super-resolution microscopy. I. Katona is a recipient of the Wellcome Trust International Senior Research Fellowship (090946/Z/09/Z). Additional support was provided by the US National Institutes of Health (NS74432) to I.S., and by the Italian Ministry of University (Grant PRIN 2009: 200928EEX4) and “Fondazione Banco di Sardegna” to M.P.

Author information

Authors and Affiliations

Authors

Contributions

B.D. and L.B. designed and performed STORM experiments and corresponding analytical tools, analyzed data, prepared the figures, and wrote the manuscript. M.L. carried out patch-clamp electrophysiological recordings, cell reconstructions, STORM imaging and data analysis. S.I.S. conducted and analyzed in vitro electrophysiological measurements as well as participated in STORM imaging and data analysis. E.S., B.P., S.G.W. and R.N. developed immunostaining, tissue processing and antibody-labeling procedures for STORM imaging and contributed to data acquisition and analysis. C.M.H. performed cell culture and electron microscopy experiments and data analysis. G.Y.B., J.C., I. Kacskovics and M.W. developed and validated antibodies. C.V. performed in vivo electrophysiology. S.-H.L. carried out in vitro electrophysiological recordings. M. Matolcsi developed mathematical analysis tools. C.S., M. Melis and M.P. designed and performed the chronic drug administration experiment. I.S. designed and supervised in vitro and in vivo electrophysiological experiments and contributed to manuscript editing. I. Katona conceived and supervised the project, performed in vitro electrophysiological recordings, and wrote the manuscript.

Corresponding author

Correspondence to István Katona.

Ethics declarations

Competing interests

J. Cervenak is a scientific researcher at ImmunoGenes Ltd.; I. Kacskovics is scientific co-founder of ImmunoGenes Ltd., a company specialized in the generation of FcRn transgenic animals for the production of polyclonal and monoclonal antibodies.

Integrated supplementary information

Supplementary Figure 1 Nanoscale localization precision and relative quantification of CB1 receptors by 3D-STORM imaging

(a) Schematic representation of the experimental paradigm for combined confocal/STORM imaging in HEK cells. Intrinsic fluorescence intensity of EGFP linked to the extracellular N-terminus of CB1 receptors was measured by confocal microscopy. The same CB1 proteins were immunolabeled by an antibody raised against the intracellular C-terminus, and subsequently by a secondary antibody tagged with an activator-reporter dye pair Cy3-A647, which was detected by STORM microscopy. (b) Confocal image of a representative HEK cell reveals CB1 receptor accumulation within the plasma membrane. (c) At lower magnification, STORM superresolution image of the same HEK cell depicts a similar subcellular CB1 localization pattern as confocal imaging. (d) To study whether the Number of Localization Points (NLP) obtained by STORM imaging and measured in a given anatomical profile reliably predicts relative protein quantity, randomly selected HEK cells (n = 46) expressing an EGFP-CB1 fusion construct at various expression levels were imaged by both confocal and STORM microscopy. Intrinsic EGFP fluorescence intensity (FI) values were measured by confocal microscopy and determined by subtracting mean background level (assessed from 3-3 Regions of Interest (ROIs), located in the extracellular blank regions (n = 138) from every image) from the mean pixel intensity. These values are plotted against the number of localization points (NLP) obtained by STORM microscopy in each imaged cell. The strong positive linear correlation between the two imaging readouts confirms that NLP values reliably predict relative protein quantity (n = 46 cells, Spearman's rank order correlation, p < 0.001). (e) The high magnification confocal image of the boxed plasma membrane segment in b illustrates the diffraction-limited blurred nature of the EGFP fluorescence signal. (f) In contrast, at higher magnification, the nanoscale localization precision of fluorophores representing CB1 receptors by STORM imaging results in crisp visualization of the same boxed plasma membrane segment compared to the confocal image shown in e. As determined from the same images, the high resolution of the STORM image was the consequence of a fluorophore localization precision of 5 nm in the lateral (x-y), and 32 nm in the axial (z) dimensions (measured as the standard deviation of localization distribution).

Supplementary Figure 2 Quantitative evaluation of the quality of STORM imaging in brain sections

(a-c) Localization precision displayed only a modest variation (1 nm or 5 nm at x-y or z directions, respectively) as a function of axial position ie. at different z distances from the focal plane. Clusters resulting from the multiple blinking of isolated fluorophores in the STORM images of CB1-immunostaining were identified, and the distribution of the distances of individual localization points from the center of mass of the clusters was plotted. (d) Histogram shows the distribution of the number of detected photons per localization point (n = 1341 LP) above the peak detection threshold in STORM images of 40000 cycles taken from CB1-immunostaining in hippocampal sections at 5 μm depth.

Supplementary Figure 3 Comparative analysis of the passive and active electrophysiological properties of regular-spiking CB1-positive perisomatic and dendritic interneurons in the CA1 subfield of the mouse hippocampus

(a-e) Whole-cell patch-clamp recordings from multipolar interneurons which were post-hoc classified as either perisomatic or dendritic interneurons based on their axonal distribution and their corresponding BDI value. Electrophysiological characterization reveals that these GABAergic interneuron types do not differ in their resting membrane potential (p = 0.19, t(30) = −1.34 summarized in a), input resistance (p = 0.17, t(30) = −1.4) (b), relative sag amplitude (p = 0.24, U = 94.5) (c), rebound potential (p = 0.25, U = 89) (d), and action potential amplitude (p = 0.15, t(30) = −1.47) (e). (f-h) However, dendritic interneurons fire faster action potentials (p = 0.0024, U = 48.5) (f), show a more marked afterhyperpolarization (p = 0.037, t(30) = −2.18) (g), and exhibit more adaptation of firing upon current injection (p = 0.013, t(30) = −2.63)) (h). Statistical comparisons of 14 perisomatic and 18 dendritic cells were performed by unpaired two-sided t-test (a,b,e,g,h) or by Mann-Whitney U test (c,d,f). Graphs show raw data and median±IQR. The measured data for each cell and for each parameter are presented in Supplementary Table.

Supplementary Figure 4 The quantitative power of CB1-immunostaining and subsequent STORM imaging is robust to various experimental conditions

(a) Electrophysiological recordings from acute hippocampal slices, tissue processing and immunostaining were carried out in parallel in two different laboratories in Irvine, CA, USA and in Budapest, Hungary. Undertaking all STORM imaging on the same setup in the latter laboratory resulted in similar normalized distribution of the number of CB1 localization points per boutons, as demonstrated in the cumulative probability plot showing the NLP values per bouton, normalized for the cell mean. Statistical analysis was done by Kolmogorov-Smirnov test, p > 0.05, n = 150 and n = 279 boutons from n = 7 and n = 6 basket cells filled and processed in Irvine and Budapest, respectively, were used in the experiment. (b) Immunostaining with two independent primary antibodies raised either in a guinea-pig52, or a transgenic (Tg) rabbit that overexpress the neonatal Fc receptor (FcRn) and have improved humoral immune responses58, and with the two corresponding secondary antibodies custom-labeled with fluorophore pairs for STORM imaging, resulted in similar normalized distribution of the number of CB1 localization points per bouton (n = 279 and n = 302 boutons from n = 6-6 basket cells stained with anti-CB1 antibody produced in guinea-pig and rabbit, respectively, Kolmogorov-Smirnov test, p > 0.1). (c-d) Whole-cell patch-clamp recordings and biocytin-filling did not affect bouton size or CB1 NLP. Biocytin-filled boutons, and an equal number of neighboring biocytin-negative, randomly chosen boutons were selected from the same images for analysis. The size of the boutons was determined by using the CB1 STORM signal outlining the terminals. No significant differences were found in the number of CB1 localization points, or in the size of boutons with or without biocytin-labeling (n = 202-202 axon terminals, Mann-Whitney U test, p = 0.20, U = 4563.5 and p = 0.31, U = 29232, respectively). Graphs show raw data and median±IQR.

Supplementary Figure 5 Comparative morphological analysis of the axon terminals of CB1-positive perisomatic and dendritic interneurons

(a-c) Deconvolved confocal images of n = 279 and n = 334 biocytin-filled boutons from n = 6 perisomatic and n = 6 dendritic cells, respectively, were analyzed for their shape descriptors. (a) Circularity describes how close the relation between the area and perimeter of the bouton shape is to that of a perfect circle. (b) Aspect ratio reflects the degree of elongation. (c) Solidity measures the area of the shape divided by its convex area, thereby describing convexity and smoothness of edges of the bouton shape. No significant differences are detected between cell types in either the circularity (p = 0.82, U = 16), aspect ratio (p = 0.70, U = 15), or solidity (p = 0.94, U = 17) of their boutons (Mann-Whitney U test). Graphs show raw data and median±IQR.

Supplementary Figure 6 CB1 density distribution on axon terminals of identified interneurons can be reliably determined under the specific imaging conditions used throughout the study

(a) To assess whether the local density of STORM labeling on axon terminals is within the dynamic range of the measurement, 10-10 ROIs (30 by 30 confocal pixels each; pixel size = 0.0064 μm2) were placed on the plasma membrane of HEK cells and biocytin-filled axon terminals to measure labeling density. Comparison of the labeling density did not reveal significant difference between boutons of perisomatic and dendritic interneurons (n = 6 cells/cell type, Mann-Whitney U test, p = 0.59, U = 14), and the vast majority of boutons fell within the range defined by the two HEK cells with the highest and lowest expression levels. Graphs show raw data and median±IQR. (b) The NLP values of boutons were averaged for each interneuron, and the mean±SD range of NLP density for interneurons was determined. This range well represents the STORM CB1 labeling density found on GABAergic axon terminals, as it includes 10 of the 12 interneurons. HEK cells (n = 20) within this range show highly linear positive correlation between intrinsic fluorescence intensity and NLP (Spearman's rank order correlation, p < 0.0001). (c) The distribution of local densities (neighboring localizations within 50 nm 3D distance from each localization point) on the boutons from (a) shows a heavy right tail indicating that the signal is not likely to be saturated. (d) The different size of perisomatic and dendritic boutons is evident regardless of the duration of the imaging. Using the same data set as in Figure 3, the perimeter of a 2D-convex hull fitted on the localization points detected before the given period of imaging was measured, and was plotted as the ratio of the perimeter of dendritic axon terminals over perisomatic boutons (median±IQR of the mean values of 6 cells per cell type is shown). The difference was significant at every time point after 250 cycles (n = 6 cells/cell type, Mann-Whitney U test, p = 0.015, U = 3). (e) Similarly, the finding that axon terminals of dendritic cells had less CB1 receptors than perisomatic boutons was also independent of the imaging duration after 350 cycles, as the difference was significant at every time point afterwards (n = 6 cells/cell type, Mann-Whitney U test, p = 0.041, U = 5). The same approach was used to compare the number of CB1 localization points per bouton between interneuron types. (f) The variance of nearest-neighbor distances between CB1 localization points within boutons was constant in both cell types after 400 cycles into imaging, indicating that running the imaging for up to 1000 cycles for each image provides reliable measurement of CB1 distribution within GABAergic axon terminals.

Supplementary Figure 7 Layer-specific electron microscopic analysis of CB1-containing GABAergic axon terminals

(a,b) To test whether quantitative information collected by 3D-STORM microscopy is comparable with data acquired by other well-established quantitative anatomical approaches, hippocampal sections were processed for immunogold labeling of CB1 receptors and analyzed by transmission electron microscopy (TEM). Random cross-sections of CB1-positive GABAergic boutons were selected from the stratum pyramidale and stratum radiatum of the CA1 subfield. The presumed GABAergic nature of an axon terminal was established by the presence of symmetrical synapses (arrowheads). Note that the vast majority of silver-intensified gold particles representing CB1 receptors are attached to the intracellular surface of the plasma membrane of axon terminals. (c,d) CB1-positive boutons found in the pyramidal layer are significantly larger (n = 3 animals, 100 boutons per layer per animal, paired two-sided t-test, p = 0.025, t(2) = 6.26 and p = 0.033, t(2) = 5.33 for area and perimeter, respectively). (g) In addition, the number of gold particles (NGP) on the plasma membrane of these perisomatic axon terminals is considerably higher than on boutons observed in the stratum radiatum (paired two-sided t-test, p = 0.036, t(2) = 5.13). (h) In contrast, the density of gold particles was not significantly different on boutons located in the two hippocampal layers (paired two-sided t-test, p = 0.064, t(2) = 3.76). These observations obtained at the synaptic population level are in general agreement with the cell-type-specific findings obtained by STORM imaging (see Figure 4). Graphs show raw data and median±IQR.

Supplementary Figure 8 Visualization of the localization coordinates of the STORM signal by 3D rendering and calculation of membrane surface distances

(a) Analysis of nanoscale distribution of STORM data was carried out using the x, y and z coordinates of each individual localization point. Their 3D positions are illustrated as atoms in Visual Molecular Dynamics. (b) First, a convex hull was fitted on the localization points, giving an approximation of the structure surface. Note that single-molecule localization-microscopy gives a more precise estimate of structural dimensions than electron microscopy22, which underestimates these parameters due to anisotropic shrinkage during tissue dehydration, as well as compared to confocal microscopy, which overestimates size due to light diffraction25. Indeed, the average bouton size based on the cross-sectional area of the polyhedrons of perisomatic and dendritic terminals are 1.33±0.04 μm2 and 0.97±0.03 μm2, respectively (mean±SEM), when measured by 3D-STORM microscopy. These values fall in between the range of electron microscopic (0.29±0.01 μm2 and 0.22±0.01 μm2); and confocal measurements (1.65±0.04 μm2 and 1.20±0.03 μm2). These data independently indicate that the convex hull approach resulted in a realistic representation of the imaged part of the bouton. This feature has previously been an exclusive advantage of the laborious serial reconstruction of electron micrographs. (c) Secondly, the distance of each localization point from the convex hull was measured, and only localizations within 80 nm from the surface were included in further analysis. This approach could also be utilized to measure the proportion of membrane-attached localization points and those which are likely intracellular receptors. These subcellularly segregated receptor populations presumably represent functionally different receptor pools, hence it is important to distinguish between them, when quantifying receptor distribution or pathological redistribution in a cell-type-specific manner. (d) Finally, the distance of each localization point from the active zone was measured as the shortest route on the polyhedron surface.

Supplementary Figure 9 Validation of the hull surface distance calculations and density measurements on model boutons

(a) To measure the sensitivity of the local density analysis on the polyhedron surface, a simulation of homogeneous and artificially enriched receptor distribution was conducted. “CB1 localization points” were randomly placed on model “bouton” comprising a sphere of 1000 nm radius, excluding a 230 nm radius area of the surface as the “active zone”. A convex hull was fitted onto these points. (b-c) To model different levels of potential perisynaptic enrichment, an increasing number of localization points were placed in random positions of the surface within a 250 nm radius of the active zone. (d) To measure localization point density on the surface, reference points were also placed at 40 nm spacing over the entire sphere, excluding the active zone. CB1 density, defined as the number of localization points within 200 nm distance of each reference point, was determined along with the distance from the edge of the active zone measured on the hull surface. The entire process was repeated 50 times for each enrichment condition. Finally, reference points per individual boutons were binned based on the distance from the synapse and averaged by bin. Altogether 50 mean values per bin per condition were used for generating graphs (median±IQR) and calculating p values using unpaired two-sided t-tests to compare perisynaptic and extrasynaptic regions. The difference between the 0–250 nm and the 1000-1250 nm bins is already significant at 20% (p < 0.0001), but not at 10% enrichment (p = 0.84). The graph for 1000% is not shown for sake of clarity, but was also highly significant (p < 0.0001).

Supplementary Figure 10 Combination of in vivo single neuron recording in a behaving mouse with post-hoc anatomical characterization and molecular imaging at the nanoscale

(a) Example traces from juxtacellular recording of a CA1 interneuron in an anesthesia-free mouse running on a spherical treadmill. A 1 sec-long recording, filtered for local field potential, and, spikes, and the raw trace are shown below each other, respectively. (b) After the recording, the cell was filled with neurobiotin. Morphological analysis of the labeled neuron was performed by confocal microscopy. Part of the axonal arbor (red), as well as its soma and some dendrites (blue), were reconstructed from four consecutive 20 μm thick sections by Neurolucida. (c) Laminar distribution analysis of more than 3000 axonal varicosities recovered from 14 serial sections classifies this cell as a dendritic interneuron (BDI < 0.5). (d) Maximum intensity projection of a deconvolved confocal image stack of individual axon terminals from the same in vivo recorded interneuron. (e) CB1-immunolabeling on these identified axon terminals is visualized by overlaying the corresponding confocal and STORM images. (f) Magnification of the boxed region of the STORM image in e illustrates the intraterminal distribution of CB1 localization points at the nanoscale level and reveals a qualitatively similar pattern as that observed in the case of in vitro-labeled interneurons in Figure 3. (g) Cumulative probability plots of normalized CB1 NLP found on individual terminals of in vivo- or in vitro-filled dendritic interneurons. The distribution of data obtained from the two experimental preparations were identical (Kolmogorov-Smirnov test, p > 0.1). Data were collected from single CB1 STORM imaging of 129 boutons from one in vivo, and of 141 boutons from 5 in vitro-filled cells and were normalized to the mean NLP value of the respective cell. (h) The variance of CB1 nearest neighbor distances is also comparable under the different experimental conditions indicating similar CB1 distribution at the nanoscale level in boutons of in vivo- or in vitro-filled dendritic interneurons (Kolmogorov-Smirnov test, p > 0.1). (i) In line with the in vitro findings, at the single bouton level, the number of CB1 localization points correlates linearly with bouton size (n = 129 axon terminals, Spearman's rank order correlation, p < 0.001). The experiment was performed on a single in vivo neurobiotin-filled neuron.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–10 (PDF 3940 kb)

Supplementary Methods Checklist (PDF 492 kb)

Supplementary Table 1: Physiological and anatomical parameters of CB1-positive regular-spiking, multipolar interneurons in the CA1 subfield of the mouse hippocampus.

AP, action potential; FWHM, full width at half maximum; AHP, after hyper polarization; BDI, bouton distribution index. (XLSX 19 kb)

Source data

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Dudok, B., Barna, L., Ledri, M. et al. Cell-specific STORM super-resolution imaging reveals nanoscale organization of cannabinoid signaling. Nat Neurosci 18, 75–86 (2015). https://doi.org/10.1038/nn.3892

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nn.3892

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing